Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of knee function and safety after iPS cell-derived cartilage treatment
jRCT1050220051Recruiting
- Sponsor
- Kyoto University Hospital
- Start
- Jun 2022
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of allogeneic induced pluripotent stem cell-derived cartilage in cartilage defect, sponsored by Kyoto University Hospital. Primary endpoint: Clinical outcome of knee function at least one year postoperatively. Started Jun 2022; status: recruiting.
02
Drugs
allogeneic induced pluripotent stem cell-derived cartilage
03
Conditions
cartilage defect
Beyond the preview
Go deeper on jRCT1050220051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1050220051.